Valley National Bancorp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$977K Sell
33,059
-2,578
-7% -$73.9K 1.19% 21
2014
Q3
$1M Buy
35,637
+1,265
+4% +$35.5K 1.16% 23
2014
Q2
$968K Buy
34,372
+4,058
+13% +$116K 1.14% 26
2014
Q1
$923K Sell
30,314
-44,619
-60% -$1.33M 1.21% 25
2013
Q4
$2.18M Buy
+74,933
New +$2.18M 2.13% 10

Other funds holding PFE

Valley National Bancorp's PFE Position: Q4 2014 in Review

Valley National Bancorp reduced its Pfizer (PFE) stake by 7.2% in Q4 2014, selling an estimated $73.9K and leaving 33,059 shares worth $977K. The position accounts for 1.19% of the portfolio, ranked #21.

Valley National Bancorp first reported a position in PFE in Q4 2013 and has held it in 5 quarters since. The position peaked at $2.18M in Q4 2013. 1,861 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Valley National Bancorp held 33,059 shares of Pfizer worth $977K as of Q4 2014.
  • Valley National Bancorp sold 2,578 Pfizer shares in Q4 2014, an estimated $73.9K.
  • Pfizer made up 1.19% of Valley National Bancorp's portfolio in Q4 2014, its #21 holding.
  • Valley National Bancorp first reported a position in Pfizer in Q4 2013 and has held it in 5 quarters since.
  • Valley National Bancorp's Pfizer position peaked at $2.18M in Q4 2013.
  • 1,861 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Valley National Bancorp's 13F filing for Q4 2014, filed 9 Feb 2015.